Secondary V(D)J recombination in B-1 cells

被引:60
|
作者
Qin, XF
Schwers, S
Yu, W
Papavasiliou, F
Suh, HY
Nussenzweig, A
Rajewsky, K
Nussenzweig, MC
机构
[1] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA
[2] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
[3] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA
[4] Univ Cologne, Inst Genet, D-50931 Cologne, Germany
关键词
D O I
10.1038/16933
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
B-1 B cells are a self-renewing population of B cells that differ from conventional B cells (B-2 cells) in that they are particularly predisposed to auto-antibody production(1-3). Although much is known about the signalling pathways that control B-1-cell growth and development (reviewed in ref. 4), less is known about why these cells are prone to produce autoreactive antibodies. Here we show that B-1 cells, like germinal-centre B cells(5-8), can express recombinase-activating genes 1 and 2 (RAG1 and RAG2) and undergo secondary V(D)J recombination of immunoglobulin genes. In addition, B cells from autoimmune-prone NZB mice show high levels of RAG messenger RNA and recombination. We propose that secondary immunoglobulin-gene rearrangements outside organized lymphoid organs may contribute to the development of autoreactive antibodies.
引用
收藏
页码:355 / 359
页数:5
相关论文
共 50 条
  • [1] Secondary V(D)J recombination in B-1 cells
    Xiao-Feng Qin
    Stephan Schwers
    Wong Yu
    Fotini Papavasiliou
    Heikyung Suh
    Andre Nussenzweig
    Klaus Rajewsky
    Michel C. Nussenzweig
    Nature, 1999, 397 : 355 - 359
  • [2] Engineering T Cells and B Cells for Immunotherapy Using V(D)J Recombination
    Nataf, Daniel
    Dotan, Iris
    Gritsenko, Natalia
    Pundak-Mintz, Carmel
    Nahmad, Alessio
    Sher, Divsha
    Horovitz-Fried, Miriam
    Barzel, Adi
    MOLECULAR THERAPY, 2018, 26 (05) : 198 - 199
  • [3] ENGINEERING T CELLS AND B CELLS FOR IMMUNOTHERAPY USING V(D)J RECOMBINATION
    Nataf, D.
    Dotan, I.
    Horovitz-Fried, M.
    Gritsenko, N.
    Pundak-Mintz, C.
    Nahmad, A.
    Barzel, A.
    HUMAN GENE THERAPY, 2019, 30 (12) : A19 - A20
  • [4] Engineering T cells and B cells for immunotherapy using V(D)J recombination
    Nataf, D.
    Gritsenko, N.
    Pundak-Mintz, C.
    Nahmad, A. D.
    Barboy, O.
    Horovitz-Fried, M.
    Dotan, I.
    Barzel, A.
    HUMAN GENE THERAPY, 2017, 28 (12) : A35 - A35
  • [5] Engineering T Cells and B Cells for Immunotherapy Using V(D)J Recombination
    Nataf, Daniel
    Pundak-Mintz, Carmel
    Dotan, Iris
    Barzel, Adi
    MOLECULAR THERAPY, 2017, 25 (05) : 25 - 26
  • [6] V(D)J RECOMBINATION IN PERITONEAL B-CELLS OF LEAKY SCID MICE
    KOTLOFF, DB
    BOSMA, MJ
    RUETSCH, NR
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06): : 1981 - 1994
  • [7] V(D)J recombination in mature B cells: A mechanism for altering antibody responses
    Papavasiliou, F
    Casellas, R
    Suh, HY
    Qin, XF
    Besmer, E
    Pelanda, R
    Nemazee, D
    Rajewsky, K
    Nussenzweig, MC
    SCIENCE, 1997, 278 (5336) : 298 - 301
  • [8] MicroRNA, miR-501 regulate the V(D)J recombination in B cells
    Kumari, Rupa
    Roy, Urbi
    Desai, Sagar
    Mondal, Arannya S.
    Nair, Rajshree R.
    Nilavar, Namrata
    Choudhary, Bibha
    Raghavan, Sathees C.
    BIOCHEMICAL JOURNAL, 2023, 480 (24) : 2061 - 2077
  • [9] A role for secondary V(D)J recombination in oncogenic chromosomal translocations?
    Davila, M
    Foster, S
    Kelsoe, G
    Yang, KY
    ADVANCES IN CANCER RESEARCH, VOL 81, 2001, 81 : 61 - 92
  • [10] V(D)J recombination
    Schatz, DG
    IMMUNOLOGICAL REVIEWS, 2004, 200 : 5 - 11